Friday, February 24


Kelsi Rutledge, an ecology and evolutionary biology graduate student, teaches a lab for Life Sciences 1: "Evolution, Ecology and Biodiversity." The life sciences division has recruited graduate students outside of the department to teach undergraduate students as well. (Angelica Ruiz/Daily Bruin)

TA shortage requires graduate students to teach outside departments

Some graduate students teach undergraduate courses outside of their departments because of a shortage in teaching assistants. There has been a teaching assistant shortage in divisions like life sciences and physical sciences because the undergraduate student population has increased faster than the graduate student population over the past few years, said Victoria Sork, dean of the life sciences division. Read more...

Kelsi Rutledge, an ecology and evolutionary biology graduate student, teaches a lab for Life Sciences 1: "Evolution, Ecology and Biodiversity." The life sciences division has recruited graduate students outside of the department to teach undergraduate students as well. (Angelica Ruiz/Daily Bruin)

The University of California Student Health Insurance Plan, which has an office in the Ashe Student Health and Wellness Center, may soon include top surgeries for male-to-female transgender students in its plan. (Jintak Han/Assistant Photo editor)

UC SHIP board looking to add surgery options for transgender students

University of California representatives are working to include certain transgender surgeries in student health insurance coverage. Attendees at the UC Student Health Insurance Plan meeting Tuesday discussed voting to add breast augmentation surgery for male-to-female transgender students to the UC SHIP plan, said David DiTullio, an Executive Oversight Board graduate representative for the Student Health Advisory Committee. Read more...

The University of California Student Health Insurance Plan, which has an office in the Ashe Student Health and Wellness Center, may soon include top surgeries for male-to-female transgender students in its plan. (Jintak Han/Assistant Photo editor)

(Justin Ma/Daily Bruin contributor)
(Justin Ma/Daily Bruin contributor)

Volunteers have gathered more than 400 soil samples for CALeDNA, a new program that aims to use DNA sequencing to map the distribution of species across California. (Courtesy of Emily Curd)
Volunteers have gathered more than 400 soil samples for CALeDNA, a new program that aims to use DNA sequencing to map the distribution of species across California. (Courtesy of Emily Curd)

Meyer Luskin donated $5 million to establish a new Center for History and Policy, which will apply historical research to modern-day problems. (UCLA Newsroom)

Alumnus Meyer Luskin donates $5M to fund center for history, policy

UCLA received a $5 million donation Wednesday to establish a center to apply historical research to modern-day problems. Alumnus Meyer Luskin, one of the namesakes of the Luskin School of Public Affairs, stipulated his gift would fund the Luskin Center for History and Policy, which will have the mission of furthering the study of historical events and how that knowledge is useful in creating effective public policy. Read more...

Meyer Luskin donated $5 million to establish a new Center for History and Policy, which will apply historical research to modern-day problems. (UCLA Newsroom)

Dr. Anne Schuchat, acting director of the Centers for Disease Control and Prevention, shared her experiences tackling global health crises at UCLA Ronald Reagan Medical Center on Monday evening. (Amy Dixon/Daily Bruin)
Dr. Anne Schuchat, acting director of the Centers for Disease Control and Prevention, shared her experiences tackling global health crises at UCLA Ronald Reagan Medical Center on Monday evening. (Amy Dixon/Daily Bruin)

UCLA Jonnson Comprehensive Cancer Center researchers are developing alternative treatments for patients with genetic mutations that do not respond to current immunotherapies for their cancers. (Courtesy of Antoni Ribas)
UCLA Jonnson Comprehensive Cancer Center researchers are developing alternative treatments for patients with genetic mutations that do not respond to current immunotherapies for their cancers. (Courtesy of Antoni Ribas)


1 2 3 156